Clinical Trial Update: Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing Ivonescimab to FOLFOX for advanced biliary tract cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• FOLFOX
• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: UNICANCER | Conditions: Biliary Tract Cancer | Phase 2 | Status: RECRUITING